Doğan, A.; İlhan, N.; Akdağ, G.; Yıldırım, S.; Seyyar, M.; Yüksel Yaşar, Z.; Erölmez, H.N.; Sürmeli, H.; Öztosun, B.; Sever, Ö.N.;
et al. Evaluating the Effectiveness of Cyclin-Dependent Kinase 4/6 Inhibitors in Early- and Very Early-Onset Metastatic Breast Cancer: A Multicenter Study. Medicina 2025, 61, 154.
https://doi.org/10.3390/medicina61010154
AMA Style
Doğan A, İlhan N, Akdağ G, Yıldırım S, Seyyar M, Yüksel Yaşar Z, Erölmez HN, Sürmeli H, Öztosun B, Sever ÖN,
et al. Evaluating the Effectiveness of Cyclin-Dependent Kinase 4/6 Inhibitors in Early- and Very Early-Onset Metastatic Breast Cancer: A Multicenter Study. Medicina. 2025; 61(1):154.
https://doi.org/10.3390/medicina61010154
Chicago/Turabian Style
Doğan, Akif, Nurullah İlhan, Goncagül Akdağ, Sedat Yıldırım, Mustafa Seyyar, Zeynep Yüksel Yaşar, Hande Nur Erölmez, Heves Sürmeli, Buğra Öztosun, Özlem Nuray Sever,
and et al. 2025. "Evaluating the Effectiveness of Cyclin-Dependent Kinase 4/6 Inhibitors in Early- and Very Early-Onset Metastatic Breast Cancer: A Multicenter Study" Medicina 61, no. 1: 154.
https://doi.org/10.3390/medicina61010154
APA Style
Doğan, A., İlhan, N., Akdağ, G., Yıldırım, S., Seyyar, M., Yüksel Yaşar, Z., Erölmez, H. N., Sürmeli, H., Öztosun, B., Sever, Ö. N., Odabaş, H., Yıldırım, M. E., Çabuk, D., Turan, N., & Gümüş, M.
(2025). Evaluating the Effectiveness of Cyclin-Dependent Kinase 4/6 Inhibitors in Early- and Very Early-Onset Metastatic Breast Cancer: A Multicenter Study. Medicina, 61(1), 154.
https://doi.org/10.3390/medicina61010154
